Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. | Barron's
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges
The Difficulties of Cloning a CEO - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva's Buffett Bump Fades After He Says Investment Wasn't His Idea - Bloomberg
Teva Picked as Bellwether Target in Generic Drug Price-Fix Case
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Faces Securities Class Action Alleging Copaxone Kickbacks
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe
Teva is on the prowl and its investors are taking notice
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
